GH Research PLC (GHRS)
9.59
-0.03
(-0.31%)
USD |
NASDAQ |
Nov 22, 14:38
GH Research Total Liabilities (Quarterly): 10.24M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.24M |
| June 30, 2024 | 8.299M |
| March 31, 2024 | 7.836M |
| December 31, 2023 | 7.332M |
| September 30, 2023 | 6.795M |
| June 30, 2023 | 7.289M |
| March 31, 2023 | 7.429M |
| December 31, 2022 | 4.546M |
| Date | Value |
|---|---|
| September 30, 2022 | 3.385M |
| June 30, 2022 | 3.095M |
| March 31, 2022 | 4.066M |
| December 31, 2021 | 2.749M |
| September 30, 2021 | 2.033M |
| June 30, 2021 | 4.592M |
| March 31, 2021 | 1.241M |
| December 31, 2020 | 0.246M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.246M
Minimum
Dec 2020
10.24M
Maximum
Sep 2024
5.074M
Average
4.569M
Median
Total Liabilities (Quarterly) Benchmarks
| Amarin Corp PLC | 219.24M |
| Jazz Pharmaceuticals PLC | 8.085B |
| Prothena Corp PLC | 60.89M |
| Iterum Therapeutics PLC | 25.78M |
| Mural Oncology PLC | 29.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.61M |
| Shareholders Equity (Quarterly) | 189.37M |